Back to homepage

Tag "Covaxin"

Bharat Biotech evinces interest to invest in K’taka

Bharat Biotech evinces interest to invest in K’taka

🕔17:43, 14.Oct 2022

Bengaluru, Oct 14 (IANS) Covaxin maker Dr. Krishna M. Ella has evinced interest in investing in Karnataka. Ella, Chairman and MD of Bharat Biotech, which produces Covaxin, met state Minister for Large and Medium Industries Dr. Murugesh R. Nirani, in Hyderabad

Read Full Article
Corbevax approved as heterologous vaccine for precaution dose: Centre

Corbevax approved as heterologous vaccine for precaution dose: Centre

🕔06:48, 11.Aug 2022

New Delhi, Aug 10 (IANS) The Centre on Wednesday approved Biological E’s Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin. In a letter to states, Union Health

Read Full Article
NHPC conducts Free Covid-19 vaccination camp

NHPC conducts Free Covid-19 vaccination camp

🕔18:40, 18.Jul 2022

Faridabad, July 18: NHPC organized a free Covid vaccination camp (covaxin & covishield) for 15 years and above (1st and 2nd dosage) and booster dose for adults on 18th July 2022 at NHPC Corporate Office, Faridabad. During the vaccination camp a total of

Read Full Article
Covaxin booster enhances vaccine effectiveness against Delta, Omicron variants: ICMR study

Covaxin booster enhances vaccine effectiveness against Delta, Omicron variants: ICMR study

🕔18:13, 15.Jun 2022

The Indian Council of Medical Research (ICMR) has found in a study that a Covaxin booster dose enhances the vaccine effectiveness against the Delta variant infection and gives protection against the Omicron variants BA.1.1 and BA.2. New Delhi, June 15

Read Full Article
NHPC conducts large scale Covid-19 vaccination camp

NHPC conducts large scale Covid-19 vaccination camp

🕔04:57, 5.May 2022

Faridabad,  May 05: NHPC organized a Covid vaccination camp (covaxin & covishield) for 15 years and above (1st and 2nd dosage) and booster dose for adults on 4th May 2022 at NHPC Corporate Office at Faridabad.  During the vaccination camp a total of

Read Full Article
A coffee table and paperback book, No Time to Hide COVID 19 was presented to the Vice President Dr M Venkaiah Naidu today

A coffee table and paperback book, No Time to Hide COVID 19 was presented to the Vice President Dr M Venkaiah Naidu today

🕔18:52, 4.May 2022

TN Ashok former Editor (Economics) of PTI The 376 page paperback book chronicles the history of SARS COV 2 and its journey as a pandemic across the globe. How India led the developing countries in containing the disease is a

Read Full Article
Ocugen to commercialise Covaxin in Mexico

Ocugen to commercialise Covaxin in Mexico

🕔06:46, 19.Apr 2022

Ocugen, a biotechnology company focused on discovering, developing, and commercialising novel gene therapies, biologicals and vaccines, and Bharat Biotech, announced that they have entered into an amendment to their agreement to expand Ocugen’s exclusive territory to include commercialisation of Covaxin

Read Full Article
Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies

Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies

🕔07:31, 4.Apr 2022

After the World Health Organisation (WHO) suspended the supply of Bharat Biotech’s Covaxin vaccine under the United Nations (UN) procurement after an inspection last month, the company has said it is working on upgrades to ensure that the production of

Read Full Article
Covaxin to be evaluated as Covid vaccine in US

Covaxin to be evaluated as Covid vaccine in US

🕔09:26, 20.Feb 2022

New Delhi, Feb 20 (IANS) India’s Covid-19 vaccine — Covaxin — will be evaluated as a vaccine candidate in the United States, Bharat Biotech said on Saturday. Covaxin is India’s indigenous Covid-19 vaccine manufactured by Bharat Biotech, which has been developed

Read Full Article
Covishield, Covaxin cleared for regular market approval

Covishield, Covaxin cleared for regular market approval

🕔07:07, 20.Jan 2022

New Delhi, Jan 20 (IANS) India’s two main vaccines — Bharat Biotechs Covaxin and Serum Institute of India’s Covishield — on Wednesday got the nod for regular market authorisation. An expert panel of Central Drugs Standard Control Organisation (CDSCO) — India’s

Read Full Article
Ensure only Covaxin is given to 15-18 group: Bharat Biotech

Ensure only Covaxin is given to 15-18 group: Bharat Biotech

🕔07:12, 19.Jan 2022

Hyderabad, Jan 19 (IANS) Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group. The Hyderabad-based vaccine maker on Tuesday said that it “received several additional reports of individuals in

Read Full Article
Indian wheat, Covid vax to reach Afghanistan via Iran

Indian wheat, Covid vax to reach Afghanistan via Iran

🕔07:09, 10.Jan 2022

New Delhi, Jan 10 (IANS) India got a helping hand from Iran to transport humanitarian assistance to Afghanistan . As External Affairs Minister Dr. S Jaishankar had a telephone conversation with his Iranian counterpart Hossein Amir Abdollahian, the latter offered

Read Full Article
Bharat Biotech targets one billion doses of intranasal vaccine annually

Bharat Biotech targets one billion doses of intranasal vaccine annually

🕔18:54, 28.Dec 2021

Hyderabad, Dec 28 (IANS) Bharat Biotech is targeting to make one billion doses of its Covid-19 intranasal vaccine annually while it is on track to achieve one billion doses of Covaxin, India’s first indigenous Covid vaccine. The Hyderabad-based vaccine maker has

Read Full Article
Only Covaxin to be administered to children aged 15-18 yrs

Only Covaxin to be administered to children aged 15-18 yrs

🕔07:16, 28.Dec 2021

New Delhi, Dec 28 (IANS) As the vaccination process for the teens aged 15 to 18 years will commence from January 3 across the nation, the government has said only Covaxin will be administered. The Centre on Monday issued guidelines for

Read Full Article
Serum Institute resumes export of Covishield to COVAX

Serum Institute resumes export of Covishield to COVAX

🕔21:04, 26.Nov 2021

New Delhi, Nov 26 (IANS) Pune-based vaccine manufacturer Serum Institute of India (SII) on Friday resumed exporting Covishield vaccine doses to COVAX, a worldwide initiative aimed at equitable access to Covid-19 vaccines. The first vaccine consignment left Pune on Friday for

Read Full Article
15 more nations recognise India’s Covid vaccines

15 more nations recognise India’s Covid vaccines

🕔12:42, 26.Nov 2021

New Delhi, Nov 26 (IANS) Fifteen more countries have recognised India’s Covid-19 vaccination certificate, taking the total number of such nations that have approved India’s vaccine certificate to 21, said the Ministry of External Affairs (MEA). “Mutual recognition of Covid-19 vaccination

Read Full Article
Serum Institute gets nod to export vaccines to COVAX

Serum Institute gets nod to export vaccines to COVAX

🕔18:00, 22.Nov 2021

New Delhi, Nov 22 (IANS) The Pune based vaccines manufacturer Serum Institute of India (SII) has got the nod to export Covid vaccines under the COVAX programme, said a source on Monday. The ministry has allowed SII to export 50

Read Full Article
Canada to allow entry of travellers fully vaccinated with Sinopharm, Sinovac, Covaxin

Canada to allow entry of travellers fully vaccinated with Sinopharm, Sinovac, Covaxin

🕔12:24, 20.Nov 2021

Ottawa, Nov 20 (IANS) Travellers who are fully vaccinated with the shots from Sinopharm, Sinovac and Covaxin will be allowed to enter Canada starting November 30, the Canadian government said. Currently, Canada only accepts travellers who have received the vaccines, including

Read Full Article
110 countries recognise India’s Covishield, Covaxin: Source

110 countries recognise India’s Covishield, Covaxin: Source

🕔07:10, 19.Nov 2021

New Delhi, Nov 19 (IANS) As of now as many as 110 countries have recognized India’s Covid vaccines — Covishield and Covaxin — and have agreed to mutual recognition of Covid-19 vaccination certificates with India, said official sources in the Union

Read Full Article
Bahrain approves Covaxin for emergency use

Bahrain approves Covaxin for emergency use

🕔16:04, 12.Nov 2021

New Delhi, Nov 12 (IANS) The National Health Regulatory Authority (NHRA) of Bahrain on Friday approved Covaxin, India’s first indigenous vaccine against Covid-19, for emergency use. Covaxin, manufactured by the Hyderabad-based pharma major Bharat Biotech, will be available in Bahrain for

Read Full Article

Search the Website

Advertiser’s Logo

Latest Posts